Bioceramics in Total Hip Arthoplasty: Hydroxyapatite Coating

William Capello, James A. D'Antonio, Michael T. Manley, Judy R. Feinberg

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Our objective is to describe the use of hydroxyapatite coatings in total hip arthroplasty. Hydroxyapatite enhances bone ingrowth and provides for a durable and lasting construct. The femoral component has performed well at 15-year minimum follow-up, with aseptic revision rates routinely less than 1%. Initial results on the acetabular side were disappointing. However, after redesign, a second-generation arc-deposited hydroxyapatite-coated cup is performing well at 4- to 7-year follow-up. Hydroxyapatite-coated implants have also been used successfully in the revision setting. Future applications include the use of hydroxyapatite coating as a means of delivering bone-enhancing drugs such as the bisphosphonates.

Original languageEnglish
Pages (from-to)153-160
Number of pages8
JournalSeminars in Arthroplasty
Volume17
Issue number3-4
DOIs
StatePublished - Sep 2006

Fingerprint

Durapatite
Hip
Bone and Bones
Diphosphonates
Thigh
Arthroplasty
Pharmaceutical Preparations

Keywords

  • bioceramics
  • hydroxyapatite
  • implant design
  • total hip arthroplasty

ASJC Scopus subject areas

  • Surgery

Cite this

Bioceramics in Total Hip Arthoplasty : Hydroxyapatite Coating. / Capello, William; D'Antonio, James A.; Manley, Michael T.; Feinberg, Judy R.

In: Seminars in Arthroplasty, Vol. 17, No. 3-4, 09.2006, p. 153-160.

Research output: Contribution to journalArticle

Capello, William ; D'Antonio, James A. ; Manley, Michael T. ; Feinberg, Judy R. / Bioceramics in Total Hip Arthoplasty : Hydroxyapatite Coating. In: Seminars in Arthroplasty. 2006 ; Vol. 17, No. 3-4. pp. 153-160.
@article{fa1a8f13a07b43b199ea7a9be7407f94,
title = "Bioceramics in Total Hip Arthoplasty: Hydroxyapatite Coating",
abstract = "Our objective is to describe the use of hydroxyapatite coatings in total hip arthroplasty. Hydroxyapatite enhances bone ingrowth and provides for a durable and lasting construct. The femoral component has performed well at 15-year minimum follow-up, with aseptic revision rates routinely less than 1{\%}. Initial results on the acetabular side were disappointing. However, after redesign, a second-generation arc-deposited hydroxyapatite-coated cup is performing well at 4- to 7-year follow-up. Hydroxyapatite-coated implants have also been used successfully in the revision setting. Future applications include the use of hydroxyapatite coating as a means of delivering bone-enhancing drugs such as the bisphosphonates.",
keywords = "bioceramics, hydroxyapatite, implant design, total hip arthroplasty",
author = "William Capello and D'Antonio, {James A.} and Manley, {Michael T.} and Feinberg, {Judy R.}",
year = "2006",
month = "9",
doi = "10.1053/j.sart.2006.09.010",
language = "English",
volume = "17",
pages = "153--160",
journal = "Seminars in Arthroplasty",
issn = "1045-4527",
publisher = "W.B. Saunders Ltd",
number = "3-4",

}

TY - JOUR

T1 - Bioceramics in Total Hip Arthoplasty

T2 - Hydroxyapatite Coating

AU - Capello, William

AU - D'Antonio, James A.

AU - Manley, Michael T.

AU - Feinberg, Judy R.

PY - 2006/9

Y1 - 2006/9

N2 - Our objective is to describe the use of hydroxyapatite coatings in total hip arthroplasty. Hydroxyapatite enhances bone ingrowth and provides for a durable and lasting construct. The femoral component has performed well at 15-year minimum follow-up, with aseptic revision rates routinely less than 1%. Initial results on the acetabular side were disappointing. However, after redesign, a second-generation arc-deposited hydroxyapatite-coated cup is performing well at 4- to 7-year follow-up. Hydroxyapatite-coated implants have also been used successfully in the revision setting. Future applications include the use of hydroxyapatite coating as a means of delivering bone-enhancing drugs such as the bisphosphonates.

AB - Our objective is to describe the use of hydroxyapatite coatings in total hip arthroplasty. Hydroxyapatite enhances bone ingrowth and provides for a durable and lasting construct. The femoral component has performed well at 15-year minimum follow-up, with aseptic revision rates routinely less than 1%. Initial results on the acetabular side were disappointing. However, after redesign, a second-generation arc-deposited hydroxyapatite-coated cup is performing well at 4- to 7-year follow-up. Hydroxyapatite-coated implants have also been used successfully in the revision setting. Future applications include the use of hydroxyapatite coating as a means of delivering bone-enhancing drugs such as the bisphosphonates.

KW - bioceramics

KW - hydroxyapatite

KW - implant design

KW - total hip arthroplasty

UR - http://www.scopus.com/inward/record.url?scp=33845319730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845319730&partnerID=8YFLogxK

U2 - 10.1053/j.sart.2006.09.010

DO - 10.1053/j.sart.2006.09.010

M3 - Article

AN - SCOPUS:33845319730

VL - 17

SP - 153

EP - 160

JO - Seminars in Arthroplasty

JF - Seminars in Arthroplasty

SN - 1045-4527

IS - 3-4

ER -